September 17, 2024

FOR IMMEDIATE RELEASE

Austin, TX— [September 17, 2024]—SubjectWell, provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell’s ability to connect patients to transformative healthcare across all geographies.

June 27, 2024

Dr. Tobias Kruse showcased Trials24’s patient recruitment strategies utilizing social media platforms such as TikTok, Instagram, and Facebook.

June 10, 2024

Trials24 exhibited at the BIO International Convention, hosted multiple meetings, and participated in an event held by BIO.NRW.

May 16, 2024

Trials24 recently showcased innovative ways to leverage Google, Facebook, Instagram, and TikTok for patient recruitment at the DGPharMed event.

May 3, 2024

Dr. Tobias Kruse recently participated in TransPerfect Life Sciences’ #C3SummitLondon on May 2, 2024. The summit featured discussions on the latest practices in clinical trials, focusing on patient recruitment and retention.

April 24, 2024

This gathering allowed Trials24 to attend partnering meetings and showcase how online patient recruitment is shortening clinical trial timelines.

April 15, 2024

Munich, Germany, Monday, April 15, 2024 – Trials24, a global patient recruitment company, is announcing its participation in the upcoming BIO International Convention in the United States from June 3-6, 2024.

April 8, 2024

Munich/Kyiv, Monday, 08 April 2024 – Trials24, a service provider accelerating patient recruitment for clinical trials globally, is announcing today its partnership with Pharmaxi, a CRO specialized in clinical trials for medicinal products, medical devices, and nutritional supplements in Poland, Ukraine, and the Western Europe region.

March 25, 2024

Trials24 participated in the 19th Munich AIDS and Infection Days, where Ann-Katrin Rueß, Global Patient Recruitment Manager, shared insights on digital strategies for recruiting clinical trial participants.

March 21, 2024

Showcasing Trials24’s solutions for effective online patient recruitment management

January 30, 2024

Trials24’s founder and TUM alumni, Dr. Tobias Kruse, shared valuable insights at Venture Labs’ Discussion on Entrepreneurship in Digital Health at the Technical University of Munich.

January 12, 2024

Trials24 reflects on key discussions and connections made at the Biotech Showcase & JPM 2024.

November 30, 2023

Trials24 took part in Nordic Life Science Days 2023, an event in the life science industry in Copenhagen on November 29-30.

November 23, 2023

On November 23, 2023, in Munich, Germany, our team immersed itself in the enriching atmosphere of the 31st BVMA Symposium organized by the German Federal Association of Contract Research Organizations.

November 9, 2023

Our company participates in Munich’s prestigious BIO-Europe partnering conference from November 6-8, 2023.

October 26, 2023

We are pleased to share our experience at the recent “KI in der Klinischen Forschung” (AI in Clinical Research) event organized by DGPharMed e.V. on October 25th, 2023, in Munich.

June 29, 2023

“Every challenge in clinical trials is an opportunity for innovation,” – Dr. Tobias Kruse.

June 22, 2023

Our CEO, Dr. Tobias Kruse, and our Business Development Director, Dr. Matthias Roos, participated in the Clinical Research Committee of Bundesverband der Pharmazeutischen Industrie.

March 30, 2023

Trials24’s CEO, Dr. Tobias Kruse, and Dr. Ulrich Granzer collaborated at an MNG Lecture Event, discussing “New Treatment Modalities: Regulatory Implications and Patient Recruitment.”

March 27, 2023

Munich, Monday, March 27, 2023 – Trials24 and Climedo are announcing the publication of their global patient survey. The goal was to gain insights into clinical trials from patients’ perspectives, focusing on barriers to participation, expectations, and suggestions for trial improvement.

March 10, 2023

Trials24 participated in the 13th Operational Excellence In Clinical Trials Summit on the 8th-9th of March 2023, in Berlin, organized by KP Morgan.

March 30, 2022

With Dr. Andrea Röthler, Head of Project Management, GKM (Gesellschaft für Therapieforschung mbH), and our CEO, Dr. Tobias Kruse, we have explored decentralized approaches for patient recruitment, emphasizing the importance of interactive engagement for sponsors seeking effective solutions.

 

March 28, 2022

The event featured discussions on decentralized clinical trials and the integration of real-world data (RWD) in research.

December 27, 2021

In our interview with Alcedis, we focused on Trials24’s innovative methods in patient recruitment for clinical trials, highlighting digital approaches to connect with potential participants who are typically hard to reach through traditional methods.

October 1, 2021

In his keynote speech, Dr. Tobias Kruse highlighted a significant obstacle in clinical trials: patient recruitment.

September 17, 2024

FOR IMMEDIATE RELEASE

Austin, TX— [September 17, 2024]—SubjectWell, provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell’s ability to connect patients to transformative healthcare across all geographies.

June 27, 2024

Dr. Tobias Kruse showcased Trials24’s patient recruitment strategies utilizing social media platforms such as TikTok, Instagram, and Facebook.

June 10, 2024

Trials24 exhibited at the BIO International Convention, hosted multiple meetings, and participated in an event held by BIO.NRW.

May 16, 2024

Trials24 recently showcased innovative ways to leverage Google, Facebook, Instagram, and TikTok for patient recruitment at the DGPharMed event.

May 3, 2024

Dr. Tobias Kruse recently participated in TransPerfect Life Sciences’ #C3SummitLondon on May 2, 2024. The summit featured discussions on the latest practices in clinical trials, focusing on patient recruitment and retention.

April 24, 2024

This gathering allowed Trials24 to attend partnering meetings and showcase how online patient recruitment is shortening clinical trial timelines.

April 15, 2024

Munich, Germany, Monday, April 15, 2024 – Trials24, a global patient recruitment company, is announcing its participation in the upcoming BIO International Convention in the United States from June 3-6, 2024.

April 8, 2024

Munich/Kyiv, Monday, 08 April 2024 – Trials24, a service provider accelerating patient recruitment for clinical trials globally, is announcing today its partnership with Pharmaxi, a CRO specialized in clinical trials for medicinal products, medical devices, and nutritional supplements in Poland, Ukraine, and the Western Europe region.

March 25, 2024

Trials24 participated in the 19th Munich AIDS and Infection Days, where Ann-Katrin Rueß, Global Patient Recruitment Manager, shared insights on digital strategies for recruiting clinical trial participants.

March 21, 2024

Showcasing Trials24’s solutions for effective online patient recruitment management

January 30, 2024

Trials24’s founder and TUM alumni, Dr. Tobias Kruse, shared valuable insights at Venture Labs’ Discussion on Entrepreneurship in Digital Health at the Technical University of Munich.

January 12, 2024

Trials24 reflects on key discussions and connections made at the Biotech Showcase & JPM 2024.

November 30, 2023

Trials24 took part in Nordic Life Science Days 2023, an event in the life science industry in Copenhagen on November 29-30.

November 23, 2023

On November 23, 2023, in Munich, Germany, our team immersed itself in the enriching atmosphere of the 31st BVMA Symposium organized by the German Federal Association of Contract Research Organizations.

November 9, 2023

Our company participates in Munich’s prestigious BIO-Europe partnering conference from November 6-8, 2023.

October 26, 2023

We are pleased to share our experience at the recent “KI in der Klinischen Forschung” (AI in Clinical Research) event organized by DGPharMed e.V. on October 25th, 2023, in Munich.

June 29, 2023

“Every challenge in clinical trials is an opportunity for innovation,” – Dr. Tobias Kruse.

June 22, 2023

Our CEO, Dr. Tobias Kruse, and our Business Development Director, Dr. Matthias Roos, participated in the Clinical Research Committee of Bundesverband der Pharmazeutischen Industrie.

March 30, 2023

Trials24’s CEO, Dr. Tobias Kruse, and Dr. Ulrich Granzer collaborated at an MNG Lecture Event, discussing “New Treatment Modalities: Regulatory Implications and Patient Recruitment.”

March 27, 2023

Munich, Monday, March 27, 2023 – Trials24 and Climedo are announcing the publication of their global patient survey. The goal was to gain insights into clinical trials from patients’ perspectives, focusing on barriers to participation, expectations, and suggestions for trial improvement.

March 10, 2023

Trials24 participated in the 13th Operational Excellence In Clinical Trials Summit on the 8th-9th of March 2023, in Berlin, organized by KP Morgan.

March 30, 2022

With Dr. Andrea Röthler, Head of Project Management, GKM (Gesellschaft für Therapieforschung mbH), and our CEO, Dr. Tobias Kruse, we have explored decentralized approaches for patient recruitment, emphasizing the importance of interactive engagement for sponsors seeking effective solutions.

 

March 28, 2022

The event featured discussions on decentralized clinical trials and the integration of real-world data (RWD) in research.

December 27, 2021

In our interview with Alcedis, we focused on Trials24’s innovative methods in patient recruitment for clinical trials, highlighting digital approaches to connect with potential participants who are typically hard to reach through traditional methods.

October 1, 2021

In his keynote speech, Dr. Tobias Kruse highlighted a significant obstacle in clinical trials: patient recruitment.